Ireland
--:--IST
Latest
Clinical Trials in Denmark / NCT06405750
Recruiting Not applicable

Left Atrial Appendage Arrhythmogenic and Thrombogenic Substrate

NCT06405750 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2024-08-01
Last updated
2026-01-15

Condition(s) studied

Atrial FibrillationStroke

Investigational drug(s) / intervention(s)

left atrial appendage closure

left atrial appendage closure: systematic closure of the left atrial appendage in addition to the planned heart surgery

Study summary

The purpose of the project is to elucidate whether it is possible to identify which patients are at risk of forming blood clots that can cause stroke based on analysis of the electrocardiogram.

In connection with the operation, the small pouch known as the auricle of the heart is closed, which can be completely removed after closing. This procedure is common in patients with atrial fibrillation to protect the brain from stroke. In the project, all patients will have this auricle closed if they agree to participate in the project.

After closure, the auricle is usually discarded. We will analyze the blood and the auricle tissue taken (if available) in connection with the operation itself, together with the analysis of the electrocardiogram recorded before the planned heart operation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * signed informed consent AND * planned any open-heart surgery: * CABG * valve repair or replacement * aorta surgery * any combination of the above Exclusion Criteria: * current endocarditis * follow-up not possible

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Rigshospitalet Copenhagen Denmark Recruiting

More University Hospital Bispebjerg and Frederiksberg trials in Denmark

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06405750 on ClinicalTrials.gov ↗ ← All trials in Denmark